DetailsChartProfilRisikomatrixNachrichtenDokumente

Candriam Equities L Biotechnology C - Thesaurierung/  LU0108459040  /

Fonds
NAV02.05.2024 Diff.+23,0400 Ertragstyp Ausrichtung Fondsgesellschaft
820,1800USD +2,89% thesaurierend Aktien Candriam ▶
     
Chart for Candriam Equities L Biotechnology C - Thesaurierung
  Titel   ISIN Performance Volatilität Sharpe Ratio
1. BIT Biotech Opportunities S DE000A3DCA95 +58,23% 33,15% 1,64
2. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) SGD LU0320765992 +21,65% 17,78% 1,00
3. Janus Henderson Horizon Biotechnology Fund A2 EUR LU2441282899 +23,49% 20,69% 0,95
4. Janus Henderson Horizon Biotechnology Fund IU2 EUR LU2441282626 +23,34% 20,71% 0,94
5. Abaris Biotech.Opportunities A EUR LU2210105669 +38,44% 37,88% 0,91
6. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse I (acc) USD LU0195948822 +20,92% 18,86% 0,91
7. F.Biotechnology Dis.Fd.W USD LU0976566496 +20,83% 18,90% 0,90
8. Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP LU0774687577 +19,90% 17,96% 0,90
9. F.Biotechnology Dis.Fd.Z USD LU1446800499 +20,54% 18,88% 0,89
10. Biotech Core Mid-Cap Fund LI0237235184 +24,21% 23,34% 0,88
...
45. Candriam Equities L Biotechnology C - Thesaurierung LU0108459040 +6,87% 16,30% 0,19